Delivery Order SPE2DB25D3110-SPE2DB25FTCUP
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,723.74, is a Delivery Order for the provision of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has an ultimate completion date of March 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $3,499.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a completion date of November 15, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $1,510.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with an ultimate completion date of February 18, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $37,673.79, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a prescription pharmaceutical product. The contract has a period of performance through November 6, 2024 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,813.61, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS medication. The contract has a completion date of February 7, 2025 and is a Firm Fixed Price Delivery Order with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,687.72, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of March 25, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,288.70, is a Firm Fixed Price Delivery Order for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has an ultimate completion date of April 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,420.05, is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has an ultimate completion date of January 7, 2025 and uses a Firm Fixed Price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,433.25, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract has an ultimate completion date of December 27, 2024 and is a firm fixed-price delivery order. The contract was not set aside for any special designation. AmerisourceBergen holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,510.60, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS medication. The contract has an ultimate completion date of March 31, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB25FTCUPDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,387.63, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract has an ultimate completion date of March 20, 2025 and is a Firm Fixed Price delivery order. This contract award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 3/19/25 |